Natco Pharma Ltd
NSE:NATCOPHARM
Natco Pharma Ltd
NSE:NATCOPHARM
Price:
778
INR
4.22%
Market Closed
Market Cap:
139.3B
INR
Balance Sheet
Balance Sheet Decomposition
Natco Pharma Ltd
Natco Pharma Ltd
| Current Assets | 50B |
| Cash & Short-Term Investments | 24.6B |
| Receivables | 14.5B |
| Other Current Assets | 10.9B |
| Non-Current Assets | 32.4B |
| Long-Term Investments | 3.7B |
| PP&E | 25.4B |
| Intangibles | 2.4B |
| Other Non-Current Assets | 995m |
Balance Sheet
Natco Pharma Ltd
Natco Pharma Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
133
|
452
|
358
|
217
|
283
|
198
|
258
|
1 111
|
1 319
|
767
|
|
| Cash |
133
|
452
|
358
|
217
|
283
|
198
|
258
|
1 111
|
1 319
|
704
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
63
|
|
| Short-Term Investments |
7
|
221
|
321
|
2 284
|
3 977
|
715
|
3 983
|
2 950
|
6 612
|
13 208
|
|
| Total Receivables |
2 012
|
2 867
|
4 971
|
6 848
|
6 077
|
7 029
|
5 903
|
8 379
|
10 336
|
14 217
|
|
| Accounts Receivables |
1 924
|
2 616
|
4 752
|
6 375
|
5 062
|
5 513
|
4 129
|
6 206
|
8 846
|
12 553
|
|
| Other Receivables |
88
|
251
|
219
|
473
|
1 015
|
1 516
|
1 774
|
2 173
|
1 490
|
1 664
|
|
| Inventory |
2 200
|
3 573
|
3 489
|
4 384
|
5 908
|
6 987
|
9 104
|
8 620
|
8 089
|
7 917
|
|
| Other Current Assets |
526
|
1 257
|
1 734
|
7 574
|
7 227
|
8 327
|
4 125
|
3 912
|
3 647
|
4 189
|
|
| Total Current Assets |
4 878
|
8 370
|
10 873
|
21 307
|
23 472
|
23 256
|
23 373
|
24 972
|
30 003
|
40 235
|
|
| PP&E Net |
7 930
|
9 164
|
11 635
|
14 927
|
18 561
|
20 936
|
22 372
|
23 084
|
23 034
|
24 350
|
|
| PP&E Gross |
0
|
9 164
|
11 635
|
14 927
|
18 561
|
20 936
|
22 372
|
23 084
|
23 034
|
24 350
|
|
| Accumulated Depreciation |
0
|
2 679
|
3 184
|
3 800
|
4 576
|
5 485
|
6 627
|
7 940
|
9 123
|
10 638
|
|
| Intangible Assets |
50
|
55
|
58
|
59
|
87
|
88
|
94
|
822
|
1 326
|
1 371
|
|
| Goodwill |
374
|
0
|
0
|
0
|
0
|
0
|
0
|
507
|
552
|
560
|
|
| Note Receivable |
536
|
591
|
554
|
701
|
633
|
726
|
451
|
625
|
616
|
966
|
|
| Long-Term Investments |
27
|
1
|
1
|
81
|
199
|
836
|
1 594
|
1 044
|
873
|
959
|
|
| Other Long-Term Assets |
27
|
36
|
55
|
76
|
79
|
36
|
35
|
37
|
170
|
622
|
|
| Other Assets |
374
|
0
|
0
|
0
|
0
|
0
|
0
|
507
|
552
|
560
|
|
| Total Assets |
13 822
N/A
|
18 217
+32%
|
23 176
+27%
|
37 151
+60%
|
43 031
+16%
|
45 878
+7%
|
47 919
+4%
|
51 091
+7%
|
56 574
+11%
|
69 063
+22%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 253
|
2 756
|
2 627
|
2 691
|
2 170
|
2 554
|
1 462
|
1 618
|
2 638
|
2 355
|
|
| Accrued Liabilities |
121
|
155
|
306
|
332
|
314
|
300
|
321
|
370
|
446
|
575
|
|
| Short-Term Debt |
1 765
|
984
|
2 216
|
1 732
|
3 863
|
3 277
|
163
|
165
|
1 650
|
3 632
|
|
| Current Portion of Long-Term Debt |
463
|
142
|
0
|
0
|
0
|
8
|
2 667
|
4 075
|
6
|
27
|
|
| Other Current Liabilities |
538
|
894
|
1 116
|
1 165
|
940
|
714
|
643
|
876
|
2 091
|
3 139
|
|
| Total Current Liabilities |
4 140
|
4 931
|
6 265
|
5 920
|
7 287
|
6 853
|
5 256
|
7 104
|
6 831
|
9 728
|
|
| Long-Term Debt |
970
|
0
|
0
|
0
|
0
|
9
|
9
|
80
|
11
|
53
|
|
| Deferred Income Tax |
116
|
147
|
150
|
139
|
116
|
259
|
413
|
301
|
124
|
2
|
|
| Minority Interest |
50
|
49
|
41
|
38
|
20
|
112
|
18
|
0
|
0
|
0
|
|
| Other Liabilities |
100
|
133
|
227
|
332
|
718
|
910
|
1 007
|
970
|
870
|
749
|
|
| Total Liabilities |
5 376
N/A
|
5 260
-2%
|
6 683
+27%
|
6 429
-4%
|
8 141
+27%
|
8 143
+0%
|
6 703
-18%
|
8 455
+26%
|
7 836
-7%
|
10 532
+34%
|
|
| Equity | |||||||||||
| Common Stock |
332
|
348
|
349
|
369
|
365
|
364
|
365
|
365
|
365
|
358
|
|
| Retained Earnings |
5 338
|
6 554
|
10 055
|
15 288
|
20 601
|
23 748
|
26 979
|
27 822
|
34 045
|
45 786
|
|
| Additional Paid In Capital |
2 783
|
6 112
|
6 178
|
15 206
|
14 048
|
13 729
|
13 915
|
14 078
|
14 065
|
12 019
|
|
| Other Equity |
7
|
57
|
89
|
141
|
124
|
106
|
43
|
371
|
263
|
368
|
|
| Total Equity |
8 446
N/A
|
12 957
+53%
|
16 493
+27%
|
30 722
+86%
|
34 890
+14%
|
37 735
+8%
|
41 216
+9%
|
42 636
+3%
|
48 738
+14%
|
58 531
+20%
|
|
| Total Liabilities & Equity |
13 822
N/A
|
18 217
+32%
|
23 176
+27%
|
37 151
+60%
|
43 031
+16%
|
45 878
+7%
|
47 919
+4%
|
51 091
+7%
|
56 574
+11%
|
69 063
+22%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
166
|
174
|
174
|
184
|
183
|
182
|
182
|
183
|
182
|
179
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
